Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617227 · ClinicalTrials.gov registry record
Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin
A clinical trial, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00617227: Completed study, sponsored by Maimonides Medical Center.
NCT00617227 is a clinical trial that has completed, run by Maimonides Medical Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00617227 has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The study is based on the hypothesis that decreased creatinine clearance may be associated with detectable vancomycin levels in patients on enteral (oral / vancomycin enemas) vancomyicn for CDAD. The objective of the study is to see whether enteral vancomycin is absorbed through the inflamed GI mucosa in CDAD, and if it is absorbed, does it achieve measurable serum concentration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-02 |
What the finished NCT00617227 record still lists
NCT00617227 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00617227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00617227 about?
NCT00617227 is a clinical study titled "Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin". The study is based on the hypothesis that decreased creatinine clearance may be associated with detectable vancomycin levels in patients on enteral (oral / vancomycin enemas) vancomyicn for CDAD. The objective of the study is to see whether enteral vancomycin is absorbed through the inflamed GI muc...
What is the current status of trial NCT00617227?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2007-10. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00617227?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia